Patent application number | Description | Published |
20080260742 | Preventives/Remedies for Cancer - The present invention provides preventives/remedies for cancer and so on. Specifically, an antibody against a protein comprising the same or substantially the same as the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 17, SEQ ID NO: 25, SEQ ID NO: 38 or SEQ ID NO: 48, a compound that inhibits the expression of the above protein or the expression of a gene for the above protein, and so on, are useful as preventives/remedies for cancer, etc., cancer cell apoptosis promoters, cancer cell growth inhibitors, and so on. | 10-23-2008 |
20090142346 | Preventive/Remedy for Cancer - A human monoclonal antibody against a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1 or SEQ ID NO: 3, its partial peptide, or a salt thereof, is useful as an agent for preventing/treating cancer, etc., an apoptosis inducer of cancer cells, a growth inhibitor of cancer cells, a cytotoxic agent against cancer cells through a host defense mechanism mediated by the Fc region of an antibody, and so on. | 06-04-2009 |
20110075880 | SPEAKER DAMPER AND SPEAKER INCLUDING THE SAME - The invention provides a speaker damper ( | 03-31-2011 |
Patent application number | Description | Published |
20110045534 | Nucleic Acid Cassette For Producing Recombinant Antibodies - The invention provides a nucleic acid cassette comprising components in the following structure: A-B-C, wherein “A” is a nucleic acid sequence encoding a light chain of a first antibody (or antigen binding domain thereof), “B” is a nucleic acid sequence encoding a 2A peptide, “C” is a nucleic acid sequence encoding a heavy chain of a second antibody (or antigen binding domain thereof), and “−” is a phosphodiester or phosphorothioate bond. Also provided are methods for making recombinant antibodies using the nucleic acid cassette of the invention, cells and vector comprising the nucleic acid cassette of the invention, and kits for making the nucleic acid cassette of the invention. | 02-24-2011 |
20120149880 | Nucleic Acid Cassette For Producing Recombinant Antibodies - The invention provides a nucleic acid cassette comprising components in the following structure: A-B-C, wherein “A” is a nucleic acid sequence encoding a light chain of a first antibody (or antigen binding domain thereof), “B” is a nucleic acid sequence encoding a 2A peptide, “C” is a nucleic acid sequence encoding a heavy chain of a second antibody (or antigen binding domain thereof), and “-” is a phosphodiester or phosphorothioate bond. Also provided is a nucleic acid cassette with the structure A-p-B-C, where “p” is a nucleic acid encoding a protease recognition site, Also provided are methods for making recombinant antibodies using the nucleic acid cassette of the invention, cells and vector comprising the nucleic acid cassette of the invention, and kits for making the nucleic acid cassette of the invention. | 06-14-2012 |
20150110794 | Anti-Human Cytomegalovirus Antibodies And Use Thereof - This disclosure provides anti-human cytomegalovirus antibodies and methods of treatment, prophylaxis, detection, and diagnosis using the same. In another aspect, the disclosure features therapeutic, prophylactic, and/or diagnostic compositions for human cytomegalovirus infection or for a human cytomegalovirus-related disease that include a binding agent (e.g., antibody) or polynucleotide disclosed herein. In some embodiments, the composition is formulated for ocular or topical administration. The compositions can further include one or more human cytomegalovirus-neutralizing antibodies, an intravenous immunoglobulin preparation, and/or one or more antiviral compounds (e.g., ganciclovir, foscamet, cidofovir, or valganciclovir). | 04-23-2015 |
Patent application number | Description | Published |
20100310957 | FUEL CELL - An oxygen-containing gas flow field is formed on a surface of a cathode side metal separator of a fuel cell. The oxygen-containing gas flow field is connected between an oxygen-containing gas supply passage and an oxygen-containing gas discharge passage. A coolant flow field is formed on the other surface of the cathode side metal separator, on the back of the oxygen-containing gas flow field. The cathode side metal separator has linear guide ridges protruding from an intermediate height area toward the oxygen-containing gas flow field to form a continuous guide flow field, and bosses protruding from the intermediate height area toward the coolant flow field to form an embossed flow field. | 12-09-2010 |
20100316924 | FUEL CELL - A fuel cell is formed by stacking first cell units and second cell units alternately. An inlet buffer and an outlet buffer are formed on a surface of a first metal separator of the first cell unit. Bosses are provided in the inlet buffer and the outlet buffer of the first metal separator. An inlet buffer and an outlet buffer are formed on a surface of the second metal separator of the first cell unit. Continuous guide ridges are formed in the inlet buffer and the outlet buffer of the second metal separator. The bosses and the continuous guide ridges are provided at positions overlapped with each other in the stacking direction. | 12-16-2010 |
20120129071 | FUEL CELL - A cell unit of a fuel cell includes a second separator. A first oxygen-containing gas flow field is formed on a surface of the second separator. An inlet buffer is connected to an inlet of the oxygen-containing gas flow field, and an outlet buffer is connected to an outlet of the first oxygen-containing gas flow field. The inlet buffer includes a first inlet buffer area having a deep groove and a second inlet buffer area, and the outlet buffer includes a first outlet buffer area having a deep groove and a second outlet buffer area. The first inlet buffer area and the first outlet buffer area have different surface areas. | 05-24-2012 |
20130183605 | FUEL CELL MEMBRANE ELECTRODE ASSEMBLY - A resin frame equipped membrane electrode assembly includes a membrane electrode assembly and a resin frame member. The membrane electrode assembly includes a solid polymer electrolyte membrane and an anode, and a cathode sandwiching the solid polymer electrolyte membrane. The resin frame member is formed around the solid polymer electrolyte membrane. The outer end of an electrode catalyst layer of the cathode protrudes beyond the outer end of a gas diffusion layer, and the resin frame member includes an inner extension protruding toward the outer periphery of the cathode to contact the outer end of the solid polymer electrolyte membrane. The inner extension of the resin frame member has an overlapped portion overlapped with the outer end of the electrode catalyst layer. | 07-18-2013 |
20150132680 | FUEL CELL - A power generation unit of a fuel cell stack includes a first metal separator, a first membrane electrode assembly, a second metal separator, a second membrane electrode assembly, and a third metal separator. A first oxygen-containing gas flow field includes a plurality of wavy flow grooves. An outlet merging area is provided at the end of the wavy flow grooves on the outlet side. The outlet merging area is connected to a plurality of straight connection flow grooves. The groove depth of the straight connection flow grooves is smaller than the groove depth of the wavy flow grooves. | 05-14-2015 |
Patent application number | Description | Published |
20090081247 | Immune adjuvant comprising ATP - This invention relates to an immunoadjuvant, which has an excellent antibody production enhancing function and is highly safe, and a vaccine composition comprising the immunoadjuvant. More specifically, the present invention relates to an immunoadjuvant comprising ATP or its pharmaceutically acceptable salt, its solvate, or its derivative having a physiological function as an active ingredient, and a vaccine composition comprising the immunoadjuvant. | 03-26-2009 |
20090252751 | Immune adjuvant comprising ubiquinone - This invention relates to an immunoadjuvant, which has an excellent antibody production enhancing function and is highly safe, and a vaccine composition comprising the immunoadjuvant. More specifically, the present invention relates to an immunoadjuvant comprising a ubiquinone represented by formula (I), and a vaccine composition comprising the ubiquinone represented by formula (I): | 10-08-2009 |
20100196384 | ANTI-HISTONE H1 MONOCLONAL ANTIBODY AND HYBRIDOMA FOR THE PRODUCTION THEREOF - The present invention discloses anti-histone H1 monoclonal antibodies, hybridomas for the production thereof, and polypeptides, which are useful for suppressing, predicting, or diagnosing transplant rejection in organ transplantation. | 08-05-2010 |
20120128706 | IMMUNE ADJUVANT COMPRISING ATP - This invention relates to an immunoadjuvant, which has an excellent antibody production enhancing function and is highly safe, and a vaccine composition comprising the immunoadjuvant. More specifically, the present invention relates to an immunoadjuvant comprising ATP or its pharmaceutically acceptable salt, its solvate, or its derivative having a physiological function as an active ingredient, and a vaccine composition comprising the immunoadjuvant. | 05-24-2012 |
Patent application number | Description | Published |
20090026996 | PULSE MOTOR CONTROL DEVICE, CONTROL METHOD, CONTROL PROGRAM, AND IMAGING APPARATUS - A pulse motor control device includes a drive pulse generator configured to generate a drive pulse in accordance with a set cycle, a pulse motor driver configured to generate an excitation current of a pattern corresponding to the number of division per one step of a pulse motor based on the drive pulse supplied from the drive pulse generator, the number of division being set in the pulse motor driver, the pulse motor driver supplying the excitation current to the pulse motor to thereby drive the pulse motor based on micro-step driving, and a controller configured to set the cycle in the drive pulse generator every time the drive pulse is supplied from the drive pulse generator. | 01-29-2009 |
20090081573 | TONER FOR DEVELOPMENT OF ELECTROSTATIC IMAGE, METHOD FOR MANUFACTURING THE SAME, DEVELOPER FOR DEVELOPMENT OF ELECTROSTATIC IMAGE, TONER CARTRIDGE, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS - A toner for development of an electrostatic image includes at least a crystalline polyester resin and a colorant. The toner shows a dielectric loss index ∈″ of 0.1 or less at 0.1 Hz and 500 V at 30° C. and 90% RH. | 03-26-2009 |
20090274972 | ELECTROSTATIC-IMAGE-DEVELOPING TONER, METHOD OF PRODUCING THE SAME, ELECTROSTATIC IMAGE DEVELOPER, IMAGE FORMING METHOD AND IMAGE FORMING APPARATUS - An electrostatic-image-developing toner includes a phosphonic acid based sequestering agent. | 11-05-2009 |
20100068643 | ELECTROSTATIC-IMAGE-DEVELOPING TONER, PROCESS FOR PRODUCING ELECTROSTATIC-IMAGE-DEVELOPING TONER, ELECTROSTATIC IMAGE DEVELOPER, AND IMAGE-FORMING APPARATUS - An electrostatic-image-developing toner includes a binder resin; a colorant; a releasing agent having a melting temperature of from about 70° C. to about 100° C.; and an ethylenediaminedisuccinic acid. | 03-18-2010 |
20110188910 | FIXING DEVICE AND IMAGE FORMING APPARATUS - A fixing device is configured to fix a toner image formed on a recording medium and includes a fixing roll, a separation claw in contact with the fixing roll, and a pressure member disposed to face the fixing roll. The fixing roll includes a metallic core and a surface layer formed on the metallic core. The surface layer is an electroless nickel plating layer containing a boron compound and a phosphorus compound. | 08-04-2011 |
20110236817 | ELECTROSTATIC IMAGE DEVELOPING TONER, METHOD FOR PRODUCING ELECTROSTATIC IMAGE DEVELOPING TONER, METHOD FOR FORMING IMAGE, AND IMAGE FORMING APPARATUS. - An electrostatic image developing toner includes a binding resin and a release agent, wherein an organic silicon compound including a siloxane bond is present in a domain of the release agent. | 09-29-2011 |
20110318063 | TONER, DEVELOPER, TONER CARTRIDGE, AND IMAGE FORMING APPARATUS - Provided is a toner wherein when a solid image formed by the toner is irradiated with incident light at an incident angle of −45° using a goniophotometer, a ratio (A/B) of a reflectance A at a light-receiving angle of +30° to a reflectance B at a light-receiving angle of −30° is about 2 or more and about 100 or less. | 12-29-2011 |
20110318682 | TONER, DEVELOPER, TONER CARTRIDGE, AND IMAGE FORMING APPARATUS - Provided is a toner wherein when a solid image formed by the toner is irradiated with incident light at an incident angle of −45° using a goniophotometer, a ratio (A/B) of a reflectance A at a light-receiving angle of +30° to a reflectance B at a light-receiving angle of −30° is about 2 or more and about 100 or less. | 12-29-2011 |
20110318683 | TONER, DEVELOPER, TONER CARTRIDGE, AND IMAGE FORMING APPARATUS - A toner contains a binder resin and a polyalkylene, wherein the following formula is satisfied: | 12-29-2011 |
20130078562 | PHOTOLUMINESCENT TONER, DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND METHOD FOR PRODUCING THE PHOTOLUMINESCENT TONER - An electrostatic image developing toner including: first toner particles which contain a first binder resin and a photoluminescent pigment; and second toner particles which contain a second binder resin and do not contain a photoluminescent pigment, wherein the proportion of the second toner particles is in a range from 5% by number to 80% by number with respect to a total number of all toner particles. | 03-28-2013 |
20130137030 | TONER, DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD - An electrostatic charge image developing toner includes toner particles containing a binder resin and pigment particles and an external additive containing fluorine resin particles, wherein the electrostatic charge image developing toner satisfies the following expression: 2≦A/B≦100, wherein A represents reflectance at an acceptance angle of +30° which is measured when a solid image is formed using the electrostatic charge image developing toner and the solid image is irradiated with incident light at an incidence angle of −45° by the use of a variable-angle photometer, and B represents reflectance at an acceptance angle of −30° which is measured when the solid image is irradiated with incident light at an incidence angle of −45° by the use of the variable-angle photometer. | 05-30-2013 |
20130244163 | ELECTROSTATIC LATENT IMAGE DEVELOPING TONER, ELECTROSTATIC LATENT IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD - An electrostatic latent image developing toner contains toner particles that contain a binder resin and a pigment; and an external additive that contains inorganic particles, a ratio (C/D) of an average maximum thickness C to an average equivalent circle diameter D in the toner particles is from 0.05 to 0.7, the inorganic particles include silicone oil-treated inorganic particles in which the amount of free silicone oil with respect to the inorganic particles is from 0.1% by weight to 10% by weight, and the amount of the silicone oil-treated inorganic particles added with respect to 100 parts by weight of the toner particles is from 0.1 part by weight to 10 parts by weight. | 09-19-2013 |
20130323633 | BRILLIANT TONER, DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS - A brilliant toner includes toner particles which at least contain a brilliant pigment, a binder resin, and a release agent; and an external additive, wherein a ratio (X/Y) of a specific surface area X (m | 12-05-2013 |
20140023964 | TONER SET, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD - Provided is a toner set including at least a first brilliant toner that contains a brilliant pigment, and a second brilliant toner that contains a brilliant pigment and exhibits a different color from the first brilliant toner. | 01-23-2014 |
20140045113 | BRILLIANT TONER, DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS - Provided is a brilliant toner containing a brilliant metallic pigment of which the surface is covered with at least one kind of metal oxides selected from a group consisting of silica, alumina, and titania, wherein the brilliant toner has a dielectric loss factor of from 10×10 | 02-13-2014 |
20140193751 | TONER SET, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD - Provided is a toner set including a brilliant toner containing a brilliant pigment and at least one kind of color toner containing a colorant, in which a ratio (G′ A/G′B) of G′A to G′B satisfies a relationship of 1≦G′A/G′B≦10, when a storage modulus in 120° C. of the brilliant toner is G′A and a storage modulus in 120° C. of the color toner is G′B. | 07-10-2014 |
20140348539 | BRILLIANT TONER, DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS - A brilliant toner includes toner particles which at least contain a brilliant pigment, a binder resin, and a release agent; and an external additive, wherein a ratio (X/Y) of a specific surface area X (m | 11-27-2014 |
20150111139 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, AND TONER CARTRIDGE - An electrostatic charge image developing toner includes a binder resin, toner particles containing an acylglycerol, and an external additive, wherein at least one of hydroxyl groups in the acylglycerol is esterified with an alkyl monocarboxylic acid that contains a substituted or unsubstituted alkyl group having from 12 to 22 carbon atoms, and a content of a portion esterified with the alkyl monocarboxylic acid that contains the alkyl group having the same carbon number is 95% by weight or greater with respect to the total weight of the acylglycerol. | 04-23-2015 |
20150111140 | BRILLIANT TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, AND TONER CARTRIDGE - A brilliant toner includes toner particles containing a brilliant pigment, and toner particles containing a yellow colorant without containing the brilliant pigment, wherein a ratio of the toner particles containing the yellow colorant without containing the brilliant pigment is 50% by number or greater. | 04-23-2015 |